Literature DB >> 17998827

Introduction to artificial neural networks.

Enzo Grossi1, Massimo Buscema.   

Abstract

The coupling of computer science and theoretical bases such as nonlinear dynamics and chaos theory allows the creation of 'intelligent' agents, such as artificial neural networks (ANNs), able to adapt themselves dynamically to problems of high complexity. ANNs are able to reproduce the dynamic interaction of multiple factors simultaneously, allowing the study of complexity; they can also draw conclusions on individual basis and not as average trends. These tools can offer specific advantages with respect to classical statistical techniques. This article is designed to acquaint gastroenterologists with concepts and paradigms related to ANNs. The family of ANNs, when appropriately selected and used, permits the maximization of what can be derived from available data and from complex, dynamic, and multidimensional phenomena, which are often poorly predictable in the traditional 'cause and effect' philosophy.

Mesh:

Year:  2007        PMID: 17998827     DOI: 10.1097/MEG.0b013e3282f198a0

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  22 in total

Review 1.  Biomarkers in autism spectrum disorder: the old and the new.

Authors:  Barbara Ruggeri; Ugis Sarkans; Gunter Schumann; Antonio M Persico
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

Review 2.  Personalized nutrition approach in pediatrics: a narrative review.

Authors:  Gregorio P Milani; Marco Silano; Alessandra Mazzocchi; Silvia Bettocchi; Valentina De Cosmi; Carlo Agostoni
Journal:  Pediatr Res       Date:  2020-11-23       Impact factor: 3.756

3.  Role of XPC, XPD, XRCC1, GSTP genetic polymorphisms and Barrett's esophagus in a cohort of Italian subjects. A neural network analysis.

Authors:  Claudia Tarlarini; Silvana Penco; Massimo Conio; Enzo Grossi
Journal:  Clin Exp Gastroenterol       Date:  2012-08-08

4.  Artificial Adaptive Systems and predictive medicine: a revolutionary paradigm shift.

Authors:  Enzo Grossi
Journal:  Immun Ageing       Date:  2010-12-16       Impact factor: 6.400

5.  Prediction of effect of pegylated interferon alpha-2b plus ribavirin combination therapy in patients with chronic hepatitis C infection.

Authors:  Tetsuro Takayama; Hirotoshi Ebinuma; Shinichiro Tada; Yoshiyuki Yamagishi; Kanji Wakabayashi; Keisuke Ojiro; Takanori Kanai; Hidetsugu Saito; Toshifumi Hibi
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

6.  Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy.

Authors:  Tetsuro Takayama; Susumu Okamoto; Tadakazu Hisamatsu; Makoto Naganuma; Katsuyoshi Matsuoka; Shinta Mizuno; Rieko Bessho; Toshifumi Hibi; Takanori Kanai
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

7.  Networks in Coronary Heart Disease Genetics As a Step towards Systems Epidemiology.

Authors:  Fotios Drenos; Enzo Grossi; Massimo Buscema; Steve E Humphries
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

8.  Development and evaluation of a simple and effective prediction approach for identifying those at high risk of dyslipidemia in rural adult residents.

Authors:  Chong-Jian Wang; Yu-Qian Li; Ling Wang; Lin-Lin Li; Yi-Rui Guo; Ling-Yun Zhang; Mei-Xi Zhang; Rong-Hai Bie
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

9.  Predicting the outcomes of combination therapy in patients with chronic hepatitis C using artificial neural network.

Authors:  Forough Sargolzaee Aval; Nazanin Behnaz; Mohamad Reza Raoufy; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2014-06-01       Impact factor: 0.660

10.  Back propagation artificial neural network for community Alzheimer's disease screening in China.

Authors:  Jun Tang; Lei Wu; Helang Huang; Jiang Feng; Yefeng Yuan; Yueping Zhou; Peng Huang; Yan Xu; Chao Yu
Journal:  Neural Regen Res       Date:  2013-01-25       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.